Table 3.
SU n=1208 |
DPP-4i n=1208 |
SGLT2i n=1208 |
GLP-1-RA n=1208 |
|
Hospitalization | 1869 | 1318 | 1349 | 1076 |
Antidiabetic drugs | 467 | 782 | 871 | 1520 |
Other free-of-charge drugs | 652 | 639 | 596 | 679 |
Outpatient services for diabetes monitoring | 34 | 31 | 22 | 30 |
Other free-of-charge outpatient services | 742 | 743 | 644 | 642 |
Total costs | 3764 | 3513 | 3482 | 3947 |
DPP-4i, dipeptidyl peptidase-4 inhibitor; GLP-1-RA, glucagon-like peptide-1 receptor agonist; SGLT2i, sodium-glucose cotransporter 2 inhibitor; SU, sulfonylurea and glinides.